Rhinocort Related Published Studies
Well-designed clinical trials related to Rhinocort (Budesonide)
An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09.19]
Aerosolized L epinephrine vs Budesonide for Postextubation Stridor A Randomized Controlled Trial. [2009.09.03]
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. [2009.09.01]
Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations. [2009.07]
Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. [2009.07]
Budesonide improves decreased airway conductance in infants with respiratory symptoms. [2009.07]
Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: a randomized placebo-controlled trial. [2009.07]
Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. [2009.06]
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. [2009.05]
Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. [2009.05]
High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. [2009.04]
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. [2009.04]
The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. [2009.03]
Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. [2009.03]
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. [2009.02.19]
A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma. [2009.02]
Budesonide for maintenance of remission in Crohn's disease. [2009.01.21]
Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2009.01.05]
Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. [2009.01]
Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. [2009.01]
Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. [2009]
Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*. [2008.12]
Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole. [2008.11.15]
Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. [2008.11]
Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. [2008.11]
Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma. [2008.10]
Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. [2008.10]
Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults. [2008.10]
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. [2008.10]
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]
Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]
Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. [2008.09]
Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2008.08.22]
Oral Budesonide for Maintenance Treatment of Collagenous Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.08.07]
[Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study] [2008.08]
Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients. [2008.08]
Budesonide for induction of remission in Crohn's disease. [2008.07.16]
Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. [2008.07]
Evidence of the in vivo esterification of budesonide in human airways. [2008.07]
Effect of disease duration on dose-response of inhaled budesonide in asthma. [2008.07]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. [2008.05]
Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers. [2008.05]
Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers. [2008.05]
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. [2008.05]
Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. [2008.05]
Comparison of single 2000-microg dose treatment vs. sequential repeated-dose 500-microg treatments with nebulized budesonide in acute asthma exacerbations. [2008.04]
Long-term effects of budesonide on inflammatory status in COPD. [2008.04]
The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. [2008.03]
Bronchodilation of formoterol administered with budesonide: Device and formulation effects. [2008.03]
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? [2008.01]
Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. [2008]
Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects. [2008]
Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease : results of a 6-month randomized clinical trial. [2008]
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. [2007.12]
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. [2007.11]
Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. [2007.10]
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.10]
Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma. [2007.10]
Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission. [2007.10]
Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. [2007.10]
Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence. [2007.09]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children. [2007.09]
The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide. [2007.08]
Comparison of the efficacy and safety of ciclesonide 160 mug once daily vs. budesonide 400 mug once daily in children with asthma. [2007.08]
Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. [2007.08]
Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. [2007.08]
Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. [2007.08]
An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteers. [2007.08]
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.07.10]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma. [2007.07]
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. [2007.06]
Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis. [2007.06]
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. [2007.05]
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. [2007.05]
Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler). [2007.03]
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. [2007.02]
Ciclesonide is more effective than budesonide in the treatment of persistent asthma. [2007]
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. [2006.12]
Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3-year results of the START study. [2006.11]
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. [2006.10]
Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis. [2006.10]
Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. [2006.09]
Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. [2006.09]
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. [2006.08.26]
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. [2006.07]
Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial. [2006.06]
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. [2006.06]
Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study. [2006.06]
A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma. [2006.06]
Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray. [2006.05]
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. [2006.05]
A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. [2006.05]
Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. [2006.05]
Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial. [2006.05]
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. [2006.05]
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma. [2006.04]
|
